Copy
August, 13 2019
Giving healthcare companies the exposure they deserve. Every Tuesday.
BioTuesdays by Kilmer Lucas
Share
Tweet
Share
Forward

FEATURED STORY

PharmAust readies pivotal trial in Australia to treat cancer in dogs

PharmAust (ASX:PAA) is gearing up to begin a pivotal Phase 2 study in Australia with its lead veterinary drug candidate, monepantel, for the treatment of lymphoma in canines, which if successful, could open the door to human use in a much larger market.

“We should have some results of the Phase 2 study in November or December this year and we’ll see where we go from there in terms of a human development program,” Roger Aston, executive chairman, says in an interview with BioTuesdays. 

“If the canine study is successful, I don’t foresee any problem enticing a Big Pharma oncology company to license and develop monepantel for human use,” he adds. “A number of centers already have expressed an interest in looking at our compound as a treatment for cancer in humans based on the work we’ve done.”
Read the Story

SELECT BRIEFS

NASDAQ:HEPA

Hepion Pharmaceuticals

Names renowned liver expert, Dr. Stephen Harrison, to its SAB
 

 

Soricimed

MD Anderson initiates pancreatic cancer trial of Soricimed’s SOR-C13
 

NASDAQ:TTNP

Titan Pharmaceuticals

Knight expands reimbursement for Titan Pharma’s Probuphine in Canada
 

TSX:ZENA

Zenabis Global

Receives cultivation license for Langley plant upping capacity by 30%
 

More Briefs


Wall Street News


About BioTuesdays

 
BioTuesdays was created in 2009 by Kilmer Lucas, a leading healthcare-only investor relations firm. Employing a unique "outsourced in-house" partnership model, Kilmer Lucas designs and executes customized IR & PR programs for its drug development, medical device, cell therapy, diagnostics and healthcare services clients. But, most of BioTuesdays' content isn't client-driven. Rather, our mission is to give as many great healthcare companies and their stories as much exposure as we can.
Want to be featured in BioTuesdays? Get in touch with us.
Copyright © 2019 Kilmer Lucas, All rights reserved.
You are receiving this email because you signed up for the BioTuesdays newsletter.
Privacy Policy

BioTuesdays
PO Box 297
Carlisle, ON L0R 1H0 

subscribe | unsubscribe | update your preferences